These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 2534057
1. Suppressive activity in recipients of non-T cell-depleted allogeneic bone marrow transplants: role of T cell-depleted syngeneic marrow. Sykes M. Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():30-3. PubMed ID: 2534057 [Abstract] [Full Text] [Related]
2. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation. Sykes M, Bukhari Z, Sachs DH. Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325 [Abstract] [Full Text] [Related]
7. The recovery of resistance to alloengraftment following lethal irradiation and administration of T cell-depleted syngeneic bone marrow. Chester CH, Sykes M, Sachs DH. Bone Marrow Transplant; 1989 Mar; 4(2):195-200. PubMed ID: 2650790 [Abstract] [Full Text] [Related]
10. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G, Ferrara JL. Cancer Res; 2001 Jan 01; 61(1):162-71. PubMed ID: 11196155 [Abstract] [Full Text] [Related]
11. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. Sykes M, Chester CH, Sundt TM, Romick ML, Hoyles KA, Sachs DH. J Immunol; 1989 Dec 01; 143(11):3503-11. PubMed ID: 2584703 [Abstract] [Full Text] [Related]
13. Mechanism of the anti-GVHD effect of IL-2. I. Protective host-type cell populations are not induced by IL-2 treatment alone. Abraham VS, Sykes M. Bone Marrow Transplant; 1991 Dec 01; 7 Suppl 1():29-32. PubMed ID: 2043882 [Abstract] [Full Text] [Related]
16. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells. Ohajekwe OA, James T, Hardy MA, Oluwole SF. Bone Marrow Transplant; 1995 Apr 01; 15(4):627-32. PubMed ID: 7655391 [Abstract] [Full Text] [Related]
17. Alloengraftment in IL-2-treated mice. Sykes M, Pearson DA. Bone Marrow Transplant; 1992 Aug 01; 10(2):157-63. PubMed ID: 1525605 [Abstract] [Full Text] [Related]
18. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. Fukui J, Inaba M, Ueda Y, Miyake T, Hosaka N, Kwon AH, Sakaguchi Y, Tsuda M, Omae M, Kamiyama Y, Ikehara S. Stem Cells; 2007 Jun 01; 25(6):1595-601. PubMed ID: 17446564 [Abstract] [Full Text] [Related]
19. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M. Transplantation; 1994 Dec 27; 58(12):1385-93. PubMed ID: 7809932 [Abstract] [Full Text] [Related]
20. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Johnson BD, Hanke CA, Becker EE, Truitt RL. Cell Immunol; 1998 Nov 01; 189(2):149-59. PubMed ID: 9790729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]